Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph C Zielinski

Showing results (1-10 of 190) with videos related to

Pageof 19
Sort By:
Oncology (Williston Park, N.Y.)|February 11, 2004
Gemcitabine, anthracycline, and taxane combinations for advanced breast cancerChristoph C Zielinski
Translational Lung Cancer Research|March 26, 2015
A phase I study of MEDI4736, NNT-PD-L1 antibody in patients with advanced solid tumorsChristoph C Zielinski
Seminars in Oncology|May 2, 2003
Making treatment choices: a physician's discussion of patients' needsChristoph C Zielinski
Clinical Breast Cancer|June 12, 2002
Gemcitabine/anthracycline combinations in metastatic breast cancerChristoph C Zielinski
ESMO Open|June 25, 2019
How I treat cancer special issueChristoph C Zielinski
Acta Medica Austriaca|March 1, 2005
[Impact of oncologic therapeutic concepts 2004]Christoph C Zielinski
ESMO Open|November 16, 2016
<i>ESMO Open-Cancer Horizons</i> and the future of oncologyChristoph C Zielinski
The Lancet. Oncology|September 29, 2022
Ukraine's neighbouring countries accept the burden of cancer care for refugeesChristiane Thallinger, Christoph C Zielinski
Cancer Treatment Reviews|February 24, 2009
Novel agents for renal cell carcinoma require novel selection paradigms to optimise first-line therapyManuela Schmidinger, Christoph C Zielinski
Annals of Thoracic Medicine|November 10, 2017
Saudi lung cancer management guidelines 2017: Improving lung cancer care in Saudi regionChristian Rolfo, Christoph C Zielinski
Pageof 19

Showing results (1-10 of 190) with videos related to

Sort By:
Pageof 19
Oncology (Williston Park, N.Y.)|February 11, 2004
Gemcitabine, anthracycline, and taxane combinations for advanced breast cancerChristoph C Zielinski
Translational Lung Cancer Research|March 26, 2015
A phase I study of MEDI4736, NNT-PD-L1 antibody in patients with advanced solid tumorsChristoph C Zielinski
Seminars in Oncology|May 2, 2003
Making treatment choices: a physician's discussion of patients' needsChristoph C Zielinski
Clinical Breast Cancer|June 12, 2002
Gemcitabine/anthracycline combinations in metastatic breast cancerChristoph C Zielinski
ESMO Open|June 25, 2019
How I treat cancer special issueChristoph C Zielinski
Acta Medica Austriaca|March 1, 2005
[Impact of oncologic therapeutic concepts 2004]Christoph C Zielinski
ESMO Open|November 16, 2016
<i>ESMO Open-Cancer Horizons</i> and the future of oncologyChristoph C Zielinski
The Lancet. Oncology|September 29, 2022
Ukraine's neighbouring countries accept the burden of cancer care for refugeesChristiane Thallinger, Christoph C Zielinski
Cancer Treatment Reviews|February 24, 2009
Novel agents for renal cell carcinoma require novel selection paradigms to optimise first-line therapyManuela Schmidinger, Christoph C Zielinski
Annals of Thoracic Medicine|November 10, 2017
Saudi lung cancer management guidelines 2017: Improving lung cancer care in Saudi regionChristian Rolfo, Christoph C Zielinski
Pageof 19